- Home
- XHR vs XERS Comparison
XHR vs XERS Comparison
Compare XHR & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | XHR | XERS |
|---|---|---|
| Founded | 2007 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.4B | 1.2B |
| IPO Year | N/A | 2018 |
Fundamental Metrics
Financial Performance| Metric | XHR | XERS |
|---|---|---|
| Price | $14.91 | $7.94 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | ★ $14.14 | $10.43 |
| AVG Volume (30 Days) | 1.0M | ★ 2.5M |
| Earning Date | 02-24-2026 | 11-06-2025 |
| Dividend Yield | ★ 3.74% | N/A |
| EPS Growth | ★ 139.32 | N/A |
| EPS | ★ 0.55 | N/A |
| Revenue | ★ $1,074,772,000.00 | $266,137,000.00 |
| Revenue This Year | $4.52 | $44.37 |
| Revenue Next Year | $3.04 | $27.87 |
| P/E Ratio | $27.00 | ★ N/A |
| Revenue Growth | 4.29 | ★ 42.05 |
| 52 Week Low | $8.55 | $3.14 |
| 52 Week High | $15.47 | $10.08 |
Technical Indicators
Market Signals| Indicator | XHR | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 60.28 | 59.42 |
| Support Level | $13.92 | $6.88 |
| Resistance Level | $14.81 | $8.42 |
| Average True Range (ATR) | 0.35 | 0.43 |
| MACD | -0.01 | 0.10 |
| Stochastic Oscillator | 71.48 | 70.38 |
Price Performance
Historical ComparisonAbout XHR Xenia Hotels & Resorts Inc.
Xenia Hotels & Resorts Inc is a real estate investment trust that invests in premium full-service, lifestyle, and urban upscale hotels and resorts across the United States. The company owns and pursues hotels in the upscale, upper upscale, and luxury segments that are affiliated with various brands. Its hotels are operated by Marriott, along with Hilton, Hyatt, Starwood, Kimpton, Aston, Fairmont, and Loews. The firm's properties are located in various regions across the U.S.: the South Atlantic, West South Central, Pacific, Mountain, and other. Xenia's revenue is divided between room, food and beverage, and other. The firm's customer groups include transient business, group business, and contract business.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).